Scientific article

Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans

Published inHuman brain mapping, vol. 29, no. 4, p. 400-410
Publication date2008

The D(2) receptors exist in either the high- or low-affinity state with respect to agonists, and while agonists bind preferentially to the high-affinity state, antagonists do not distinguish between the two states. [(11)C]-(+)-PHNO is a PET D(2) agonist radioligand and therefore provides a preferential measure of the D(2) (high) receptors. In contrast, [(11)C]raclopride is an antagonist radioligand and thus binds with equal affinity to the D(2) high- and low-affinity states. The aim was to compare the brain uptake, distribution and binding characteristics between [(11)C]-(+)-PHNO and [(11)C]raclopride in volunteers using a within-subject design. Both radioligands accumulated in brain areas rich in D(2)/D(3)-receptors. However, [(11)C]-(+)-PHNO showed preferential uptake in the ventral striatum and globus pallidus, while [(11)C]raclopride showed preferential uptake in the dorsal striatum. Mean binding potentials were higher in the putamen (4.3 vs. 2.8) and caudate (3.4 vs 2.1) for [(11)C]raclopride, equal in the ventral-striatum (3.4 vs. 3.3), and higher in the globus pallidus for [(11)C]-(+)-PHNO (1.8 vs. 3.3). Moreover [(11)C]-(+)-PHNO kinetics in the globus pallidus showed a slower washout than other regions. One explanation for the preferential binding of [(11)C]-(+)-PHNO in the globus pallidus and ventral-striatum could be the presence of a greater proportion of high- vs. low-affinity receptors in these areas. Alternatively, the observed distribution could also be explained by a preferential binding of D(3)-over-D(2) with [(11)C]-(+)-PHNO. This differential binding of agonist vs. antagonist radioligand, especially in the critically important region of the limbic striatum/pallidum, offers new avenues to investigate the role of the dopamine system in health and disease.

  • Adult
  • Binding, Competitive/drug effects/physiology
  • Brain Mapping/methods
  • Carbon Radioisotopes
  • Corpus Striatum/diagnostic imaging/metabolism
  • Dopamine/metabolism
  • Dopamine Agonists/metabolism/pharmacokinetics
  • Dopamine Antagonists/metabolism/pharmacokinetics
  • Dopamine D2 Receptor Antagonists
  • Female
  • Globus Pallidus/diagnostic imaging/metabolism
  • Humans
  • Male
  • Neostriatum/diagnostic imaging/metabolism
  • Oxazines/metabolism/pharmacokinetics
  • Positron-Emission Tomography/methods
  • Raclopride/metabolism/pharmacokinetics
  • Receptors, Dopamine D2/agonists/metabolism
  • Substantia Nigra/diagnostic imaging/metabolism
  • Time Factors
  • Tissue Distribution
Citation (ISO format)
GRAFF-GUERRERO, Ariel et al. Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans. In: Human brain mapping, 2008, vol. 29, n° 4, p. 400–410. doi: 10.1002/hbm.20392
Main files (1)
Article (Published version)
ISSN of the journal1065-9471

Technical informations

Creation03/16/2017 3:18:00 PM
First validation03/16/2017 3:18:00 PM
Update time03/15/2023 1:35:05 AM
Status update03/15/2023 1:35:05 AM
Last indexation10/19/2023 3:37:48 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack